High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis

High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis

High-dose rifampicin (HDR) is now undergoing clinical trials to improve the efficacy of anti-tuberculosis treatment (ATT). However, the influence of HDR in the modulation of different cytokines, chemokines/growth factors, microbial translocation markers (MTMs), and acute-phase proteins (APPs) in pul...

Full description

Bibliographic Details
Main Authors: Gokul Raj Kathamuthu, Perumal Kannabiran Bhavani, Manjula Singh, Jitendra Kumar Saini, Ashutosh Aggarwal, Mohammed Soheb S. Ansari, Rajiv Garg, Subash Babu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pharmacology
Subjects:
pulmonary tuberculosis
high-dose rifampicin
cytokines
chemokines
growth factors
acute-phase proteins
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.896551/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.896551/full

Similar Items